Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

USTEKINUMAB vs VALACYCLOVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

USTEKINUMAB vs VALACYCLOVIR: Safety Overview

Metric USTEKINUMAB VALACYCLOVIR
Total FAERS Reports 85,332 13,138
Deaths Reported 4,519 812
Death Rate 5.3% 6.2%
Hospitalizations 17,127 6,169
Average Patient Age 48.1 yrs 60.9 yrs
% Female Patients 60.3% 56.3%
FDA Approval Date N/A Apr 3, 2012
Manufacturer SANDOZ INC ST. MARY'S MEDICAL PARK PHARMACY
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription